In last trading session, Cortexyme Inc. (NASDAQ:CRTX) saw 0.48 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $10.68 trading at $0.12 or 1.14% at ring of the bell on the day assigns it a market valuation of $316.13M. That closing price of CRTX’s stock is at a discount of -1042.13% from its 52-week high price of $121.98 and is indicating a premium of 2.06% from its 52-week low price of $10.46. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.8 million shares which gives us an average trading volume of 2.33 million if we extend that period to 3-months.
For Cortexyme Inc. (CRTX), analysts’ consensus is at an average recommendation of a Hold while assigning it a mean rating of 2.90. Splitting up the data highlights that, out of 6 analysts covering the stock, 2 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 1 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.68 in the current quarter.
Cortexyme Inc. (NASDAQ:CRTX) trade information
Upright in the green during last session for gaining 1.14%, in the last five days CRTX remained trading in the red while hitting it’s week-highest on Tuesday, 01/11/22 when the stock touched $10.68 price level, adding 11.3% to its value on the day. Cortexyme Inc.’s shares saw a change of -15.37% in year-to-date performance and have moved -11.37% in past 5-day. Cortexyme Inc. (NASDAQ:CRTX) showed a performance of -9.95% in past 30-days. Number of shares sold short was 8.87 million shares which calculate 6.44 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $38.50 to the stock, which implies a rise of 72.26% to its current value. Analysts have been projecting $2.00 as a low price target for the stock while placing it at a high target of $96.00. It follows that stock’s current price would drop -798.88% in reaching the projected high whereas dropping to the targeted low would mean a gain of 81.27% for stock’s current value.
Cortexyme Inc. (CRTX) estimates and forecasts
Statistics highlight that Cortexyme Inc. is scoring comparatively lower than the scores of other players of the relevant industry. The company lost -80.07% of value to its shares in past 6 months, showing an annual growth rate of -7.98% while that of industry is 7.90. Apart from that, the company came lowering its revenue forecast for fiscal year 2022. The company is estimating its revenue growth to increase by 1.40% in the current quarter and calculating 34.60% increase in the next quarter.
In 2022, company’s earnings growth rate is likely to be around -35.60% while estimates for its earnings growth in next 5 years are of 18.30%.
Cortexyme Inc. is more likely to be releasing its next quarterly report on October 29 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Cortexyme Inc. (NASDAQ:CRTX)’s Major holders
Insiders are in possession of 32.98% of company’s total shares while institution are holding 59.03 percent of that, with stock having share float percentage of 88.08%. Investors also watch the number of corporate investors in a company very closely, which is 59.03% institutions for Cortexyme Inc. that are currently holding shares of the company. EPIQ Capital Group, LLC is the top institutional holder at CRTX for having 3.95 million shares of worth $362.39 million. And as of Sep 29, 2021, it was holding 13.23% of the company’s outstanding shares.
The second largest institutional holder is Capital World Investors, which was holding about 3.49 million shares on Sep 29, 2021. The number of shares represents firm’s hold over 11.67% of outstanding shares, having a total worth of $319.62 million.
On the other hand, Growth Fund Of America Inc and Smallcap World Fund are the top two Mutual Funds which own company’s shares. As of Sep 29, 2021, the former fund manager was holding 2.49 million shares of worth $228.67 million or 8.35% of the total outstanding shares. The later fund manager was in possession of 2.23 million shares on Sep 29, 2021, making its stake of worth around $204.16 million in the company or a holder of 7.45% of company’s stock.